Prostate cancer
Serum PSP94 Utility in Management of Patients with Raised PSA in Multicentric Study
Who can joinAdults
Age40+ years
Kind of studyObservational: no new treatment
What it testsWatches and records only
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Last updated on the registry 7 Apr 2025. Please confirm with the hospital that this trial is still taking patients.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
ICMR-National Institute for Research in Reproductive and Child Health (ICMR-NIRRCH)MumbaiDirections ↗
Registry summary (technical)
Utility of estimating serum PSP94 levels in management of patients with raised PSA in clinical setting: A multicentric study.
Sponsor: Indian Council of Medical Research (ICMR)
CTRI/2024/11/076259 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 7 Apr 2025 · read by us 5 Nov 2026